Population
Older adults suffering from multiple diseases (multimorbid patients aged 65 and older)
Design
Editorial
Key result
The FORTA (fit for the aged) classification is proposed to guide drug prioritization in older adults, addressing the lack of evidence-based guidelines and the risks of polypharmacy.
Authors
Loading...
Guideline-driven polypharmacy raises harm risk in multimorbid older adults; challenges single-disease paradigms and supports integrated deprescribing trials.
Strict adherence to disease-specific guidelines in multimorbid older adults leads to harmful polypharmacy, necessitating structured prioritization tools like the FORTA classification.
Martin Wehling (2011) conducted a letter in Polypharmacy in elderly, multimorbid patients. FORTA (fit for the aged) classification was evaluated. The FORTA (fit for the aged) classification is proposed to guide drug prioritization in older adults, addressing the lack of evidence-based guidelines and the risks of polypharmacy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: